Which is the preferred infusion therapy (Efgartigimod alfa, eculizumab or ravulizumab) for patients not responding to oral treatment with Seropositive Generalized Myasthenia?   


Answer from: at Academic Institution
Comments
at Phoebe Putney Health System
Thank you so much for such a detailed answer. This...
at First Choice Neurology
Really excellent summary. Very helpful.
Sign in or Register to read more